Stockreport

Solid Biosciences Provides Update On SGT-001 Clinical Development Program For Duchenne Muscular Dystrophy

Solid Biosciences Inc.  (SLDB) 
Last solid biosciences inc. earnings: 8/14 07:25 am Check Earnings Report
US:NASDAQ Investor Relations: investors.solidbio.com/investor-relations
PDF - Full Clinical Hold Letter from the FDA Received; Company to Respond in the Coming Weeks - - Manufacturing-related Partial Clinical Hold on the High Dose of SGT-001 Re [Read more]